Journal
AMERICAN JOURNAL OF PUBLIC HEALTH
Volume 99, Issue -, Pages S345-S350Publisher
AMER PUBLIC HEALTH ASSOC INC
DOI: 10.2105/AJPH.2008.143081
Keywords
-
Categories
Funding
- MedImmune, Pfiza, the Centers for Disease Control and Prevention [5U01Ip000022-04]
- Veterans Adminstration [1.TPS[CSP 403C]]
- Agency for Healthcare Research and Quality [HHSA290-2005-0042.ITO2]
Ask authors/readers for more resources
In 2007 the National Vaccine Program, along with the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Health Resources and Services Administration, sponsored a public conference titled Vaccine Safety Evaluation: Post Marketing Surveillance The objective was to discuss enhanced approaches to postlicensure evaluation of vaccine safety, including active and passive surveillance systems and special studies. The conference participants reviewed the evolution of the assessment of vaccine safety, detailed current national approaches to postmarketing safety, and offered new approaches to evaluating vaccine safety. A number of the participants recommended that information systems be expanded to include reliable information on vaccination and health outcomes in large populations. We summarize the major meeting presentations and discussions. (Am J Public Health. 2009;99:S345-S350. doi.10.2105/AJPH.2008.143081)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available